- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
FDA clears online visual acuity test
The FDA describes the test as a web-based, self-guided software application that consumers can access using a touchscreen mobile device and internet-connected computer.
The FDA has cleared an online visual acuity test, the Visibly Digital Acuity Product (Visibly Inc.), for use.1
The FDA describes it as a web-based, self-guided software application that consumers can access using a touchscreen mobile device and internet-connected computer.
Adults aged 22 to 40 years who can perform an in-home self-test can use the test to help evaluate visual acuity, the FDA said.
“The application’s recommendations are intended to be supportive recommendations that will be used by an eye care provider, along with the patient’s medical history and profile, prior corrective eyewear prescriptions, and subjective vision data,” according to the FDA website. “This device does not provide screening or diagnosis of eye health or other disease and does not replace an eye health exam with a licensed provider.”
After the patient completes the test, the vision results are sent eye care professionals to evaluate and follow-up with the patient, for corrective lens prescription renewal online or referral for an in-person eye examination.
Reference
1. Larkin H. JAMA. Online visual acuity test cleared. 2022;328(13):1290. doi:10.1001/jama.2022.15443
